Nemolizumab Alternatives Compared
Nemolizumab | Dupixent (dupilumab) | Dupilumab |
|
---|
Nemolizumab | Dupixent (dupilumab) | Dupilumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Prurigo Nodularis, Atopic Dermatitis. Nemolizumab may also be used for purposes not listed in this medication guide. |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more |
Prescription only
Prescribed for Eosinophilic Esophagitis, Chronic Rhinosinusitis With Nasal Polyps, Eczema, Prurigo Nodularis, Asthma, Asthma - Maintenance, Atopic Dermatitis, COPD, Urticaria. Dupilumab may also be... View more |
Related suggestions Atopic Dermatitis
Prurigo Nodularis
|
|||||||
More about Nemolizumab | More about Dupixent (dupilumab) | More about Dupilumab | ||||||||
Ratings & Reviews | ||||||||||
Nemolizumab has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Dupixent has an average rating of 7.3 out of 10 from a total of 501 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 20% reported a negative effect. |
Dupilumab has an average rating of 7.3 out of 10 from a total of 525 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Nemolizumab side effects |
View all Dupixent side effects |
View all Dupilumab side effects |
||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Dupixent prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Nemluvio |
N/A |
Dupixent | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
453.6 hours |
N/A |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 150 drugs are known to interact with Nemolizumab:
|
A total of 94 drugs are known to interact with Dupixent:
|
A total of 94 drugs are known to interact with Dupilumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
March 28, 2017 |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.